Molecular imaging can detect and quantify pathophysiological processes underlying heart
failure, complementing evaluation of cardiac structure and function with other imaging …

In this issue of JAMA Cardiology, Perera and coauthors1 report that myocardial viability
status has no influence on the outcomes associated with either percutaneous …

Ischemic heart disease represents a significant global burden of morbidity and mortality.
While revascularization strategies are well defined in acute settings, there are uncertainties …

Because ischemic cardiomyopathy representsthe only form of left ventricular (LV) systolic
dysfunction that may derive benefit from coronary artery revascularization, this treatment …

The currently available evidence showed no apparent benefit of PCI in severe ischemic
cardiomyopathy as compared to OMT, but that CABG improves outcomes in this patient …

Background The effectiveness of percutaneous coronary intervention (PCI) for chronic total
occlusion (CTO) is still uncertain, especially for patients with ischemic left ventricular …

In the 1980s, Dr. Rahimtoola proposed that chronic myocardial ischemia can lead to
hibernation, an adaptive state of left ventricular (LV) systolic dysfunction that can be …

Background Complete revascularization of coronary disease has been linked to improved
outcomes in patients with preserved left ventricular (LV) function. Objectives To identify the …

The American College of Cardiology (ACC)/American Heart Association (AHA) and the
Society for Cardiac Angiography and Interventions (SCAI) published the 2021 Coronary …

The concept of myocardial viability is usually referred to areas of the myocardium, which
show contractile dysfunction at rest and in which contractility is expected to improve after …